Flux Power Holdings Inc vs IDEXX Laboratories, Inc. — how do they compare? Flux Power Holdings Inc trades at $0.46 (market cap $9.97M), while IDEXX Laboratories, Inc. trades at $518.89 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 4055.2× Flux Power Holdings Inc's market cap, and Flux Power Holdings Inc is more actively traded (817,320 versus 692,164). Which is the better fit depends on your goals — on Pluang, investors hold Flux Power Holdings Inc for 20 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| FLUX | IDXX | |
|---|---|---|
Market Cap | $9.97M | $40.43B |
Volume | 817,320 | 692,164 |
Sector | Industrials | Health |
52-Week High | $6.66 | $766.68 |
52-Week Low | $0.41 | $504.70 |
Typical Hold Time | 20 Days | 46 Days |
Enterprise Value | $18.18M | $41.32B |
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.49, down 0.55% today, amid ongoing acquisition interest from Solidion Technology. The stock shows bearish technical signals with negative moving averages, while fundamentals reveal declining revenue from $66M in 2025 to $42M in 2026 and persistent net losses. Despite unanimous analyst buy ratings, recent earnings misses and negative profitability metrics (-17.68% net margin) highlight operational challenges.
The outlook remains speculative with acquisition potential offering upside, but fundamental weakness and cash flow concerns pose significant risks. Investors face a binary outcome between takeover premium and continued operational losses in the competitive energy storage sector.
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →